Discover 1,139 paid clinical trials in Victorville, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,139
Active & Responsive
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse
for
Volume Loss (Soft Tissue Ptosis or Atrophy )
Location: Pasadena CA
Sponsor: Kalpna Kay Durairaj, MD, FACS
Sex: All
Age: 21 - 65
Code: NCT07419854
Recruiting
Active & ResponsiveNew
Dual Modality Treatment of Androgenic Alopecia With KeraFactor® Solution and Revian® LED Light Therapy
for
Androgenic Alopecia, Female Pattern Hair Loss, Hair Loss
Location: Pasadena CA
Sponsor: K. Kay Durairaj, MD, FACS, A Medical Corporation
Sex: Female
Age: 35 - 55
Code: NCT07810504
Recruiting
Active & Responsive
A Trial of CRD-4730 in HFrEF
for
Heart Failure With Reduced Ejection Fraction (HFrEF)
Location: Pasadena CA, Bloomfield Hills MI
Sponsor: Cardurion Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07750873
Phase2, Recruiting
Active & Responsive
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
for
Metastatic Non-small Cell Lung Cancer
Location: Fullerton CA, Newport Beach CA, Goodyear AZ,
Sponsor: NovoCure GmbH
Sex: All
Age: 18+
Code: NCT06216301
Phase3, Recruiting
Active & Responsive
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
for
Breast Neoplasms, Brain Neoplasms, Neoplasms by Site, Neoplasms,
Location: Fullerton CA, Los Angeles CA, Houston TX, Urbana IL,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05386108
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for
Carcinoma, Non-Small-Cell Lung
Location: Fullerton CA, Los Angeles CA, Long Beach CA, Gilbert AZ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06623422
Phase3, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Fullerton CA, Los Alamitos CA, Chandler AZ, Gilbert AZ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase3, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
for
Generalized Myasthenia Gravis
Location: Fullerton CA, Orange CA, Los Angeles CA, Phoenix AZ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06744920
Phase3, Recruiting
Active & Responsive
Acupuncture and Chinese Herbal Medicine for Long COVID
for
Long COVID
Location: Whittier CA
Sponsor: Southern California University of Health Sciences
Sex: All
Age: 18+
Code: NCT07285707
Recruiting
Active & Responsive
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: Whittier CA, Los Angeles CA, San Francisco CA,
Sponsor: Zenith Epigenetics
Sex: Male
Age: 18+
Code: NCT04986423
Phase2, Recruiting
Active & Responsive
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
for
Colorectal Cancer
Location: Whittier CA, Orange VA, Los Angeles CA, La Jolla CA,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06562543
Recruiting
Active & Responsive
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
for
Urinary Incontinence,Stress
Location: Montebello CA, Los Angeles CA, Lakewood CO, Bellevue WA,
Sponsor: Eli Lilly and Company
Sex: Female
Age: 18+
Code: NCT07202884
Phase3, Recruiting
Active & Responsive
A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade
for
Fentanyl Overdose, Fentanyl Poisoning
Location: Glendale CA
Sponsor: Clear Scientific, Inc.
Sex: All
Age: 18 - 55
Code: NCT07459166
Phase2, Recruiting
Active & Responsive
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine